Estradiol phosphate: Difference between revisions
CSV import |
CSV import |
||
| Line 25: | Line 25: | ||
[[Category:Transgender and medicine]] | [[Category:Transgender and medicine]] | ||
{{No image}} | {{No image}} | ||
== Estradiol_phosphate == | |||
<gallery> | |||
File:Estradiol_17-phosphate.svg|Estradiol 17-phosphate | |||
</gallery> | |||
Revision as of 23:58, 24 February 2025
Estradiol phosphate is a steroid and estrogen that is used in hormone therapy. It is a prodrug of estradiol, and when administered into the body, it is converted into estradiol. Estradiol phosphate is used in the treatment of menopausal symptoms, hormone-sensitive cancers, and in hormone replacement therapy for transgender women.
Pharmacology
Estradiol phosphate is a prodrug of estradiol, meaning it is metabolized into estradiol in the body. It is administered via intramuscular injection, and has a longer duration of action compared to estradiol. This is due to the slow release of estradiol from the injection site, and the slow conversion of estradiol phosphate into estradiol.
Medical uses
Estradiol phosphate is used in the treatment of menopausal symptoms such as hot flashes and vaginal dryness. It is also used in the treatment of hormone-sensitive cancers such as breast cancer and prostate cancer. In addition, estradiol phosphate is used in hormone replacement therapy for transgender women, to help them develop secondary sexual characteristics.
Side effects
Like all estrogens, estradiol phosphate can have side effects. These can include nausea, breast tenderness, and an increased risk of blood clots. Long-term use of estradiol phosphate can also increase the risk of endometrial cancer and breast cancer.
See also
Estradiol_phosphate
-
Estradiol 17-phosphate

